Department of Internal Medicine, Englewood Hospital and Medical Center, Seton Hall University-Hackensack Meridian School of Medicine, Englewood, New Jersey.
Department of Medicine, Division of Cardiovascular Medicine, University of Iowa, Hospitals and Clinics, Iowa, Iowa.
Am J Cardiol. 2019 Jun 1;123(11):1816-1821. doi: 10.1016/j.amjcard.2019.02.038. Epub 2019 Mar 9.
In the setting of cardiogenic shock (CS), impaired biventricular function can cause acute decrease in renal function via reduced renal perfusion and increased renal venous pressure. We sought to analyze the characteristics and outcomes of patients hospitalized with CS who utilized renal replacement therapy (hemodialysis) for acute kidney injury (AKI-HD). We utilized data from the National Inpatient Sample to calculate national rates of in-hospital mortality, use of temporary mechanical support, vascular injury requiring surgery, length of stay (LOS) and hospitalization cost from 2010 to September 2015. We compared the in-hospital outcomes between CS with AKI-HD and a propensity score-matched group without AKI-HD. We identified 6,076 hospitalizations (weighted n = 24,272) with CS and AKI-HD and 76,878 (weighted n = 378,553) with CS not AKI-HD. Among these cases 48.1% (n = 39,403, weighted n = 193,746) had ST elevation myocardial infarction as the cause of CS. Patients with CS and AKI-HD had higher comorbidity burden and they were also more likely to receive mechanical circulatory support device (absolute standardized difference >10% for all comparisons) compared with CS patients without AKI-HD. After matching 4,457 cases for patient-level and hospital-level characteristics, CS with AKI-HD was associated with significantly higher in-hospital mortality (75.74% vs 51.58%, p <0.001), use of temporary mechanical support (24.0% vs 19.3%, p <0.001), LOS (21.4 vs14.4 days, p <0.001) and cost ($80,406 vs $52,833, p <0.0001). AKI-HD occurred in approximately 6% of patients with CS in years 2010 to 2015 and was associated with significantly increased in-hospital morbidity and mortality, LOS, and cost.
在心源性休克(CS)的情况下,双心室功能受损会通过降低肾灌注和增加肾静脉压导致急性肾功能下降。我们试图分析因急性肾损伤(AKI-HD)接受肾脏替代治疗(血液透析)的 CS 住院患者的特征和结局。我们利用国家住院患者样本的数据,计算了 2010 年至 2015 年 9 月期间 CS 患者院内死亡率、临时机械支持的使用、需要手术的血管损伤、住院时间(LOS)和住院费用的全国发生率。我们比较了 CS 合并 AKI-HD 患者与无 AKI-HD 的倾向评分匹配组的院内结局。我们确定了 6076 例 CS 合并 AKI-HD 的住院治疗(加权 n=24272)和 76878 例 CS 不合并 AKI-HD(加权 n=378553)。在这些病例中,48.1%(n=39403,加权 n=193746)的 CS 病因是 ST 段抬高型心肌梗死。与 CS 不合并 AKI-HD 的患者相比,CS 合并 AKI-HD 的患者有更高的合并症负担,并且更有可能接受机械循环支持设备(所有比较的绝对标准化差异>10%)。在对患者水平和医院水平的特征进行匹配后,CS 合并 AKI-HD 与更高的院内死亡率(75.74% vs 51.58%,p<0.001)、临时机械支持的使用(24.0% vs 19.3%,p<0.001)、LOS(21.4 天 vs 14.4 天,p<0.001)和费用(80406 美元 vs 52833 美元,p<0.0001)相关。2010 年至 2015 年,AKI-HD 约占 CS 患者的 6%,与显著增加的院内发病率和死亡率、LOS 和费用相关。